APTOSE BIOSCIENCES INC (APTO) Stock Analyst Ratings
NASDAQ:APTO - Nasdaq - CA03835T4081 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to APTO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 85.85. This target is 4920.47% above the current price.
APTO was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about APTO.
In the previous month the buy percentage consensus was at a similar level.
APTO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-11-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-12 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-06-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-06-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-06-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-06-07 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-05-09 | Oppenheimer | Reiterate | Outperform |
| 2023-05-09 | RBC Capital | Reiterate | Outperform |
| 2023-05-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-27 | Canaccord Genuity | Maintains | Buy |
| 2023-03-24 | RBC Capital | Reiterate | Outperform |
| 2022-11-02 | RBC Capital | Maintains | Outperform |
| 2022-05-10 | RBC Capital | Maintains | Outperform |
| 2021-12-21 | HC Wainwright & Co. | Maintains | Buy |